18 October 2018 Written by CN1699 Services Article viewed 12 times (0 times in the last week)

Deep Intelligent Pharma announced that it has raised a US$15 million series B round of financing from Sequoia Capital China. It operates an artificial intelligence (AI) technology and blockchain technology driven platform, which helps pharmaceutical companies to accelerate drug discovery, development, and medical affairs.


Written by: Sophy Yang

Date: October 9, 2018

Read full article: ChinaMoneyNetwork

Grace T

Marketing Manager - CN1699 Services